IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors
出版年份 2021 全文链接
标题
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors
作者
关键词
-
出版物
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 4, Pages e002460
出版商
BMJ
发表日期
2021-04-21
DOI
10.1136/jitc-2021-002460
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeted deletion of PD-1 in myeloid cells induces antitumor immunity
- (2020) Laura Strauss et al. Science Immunology
- Interleukin‐6‐mediated resistance to immunotherapy is linked to impaired myeloid cell function
- (2020) Elham Beyranvand Nejad et al. INTERNATIONAL JOURNAL OF CANCER
- Host genetics and tumor environment determine the functional impact of neutrophils in mouse tumor models
- (2020) Marit van Elsas et al. Journal for ImmunoTherapy of Cancer
- Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy
- (2020) Elham Beyranvand Nejad et al. Journal for ImmunoTherapy of Cancer
- Interleukin 6 (IL-6) promotes Brucella abortus clearance by controlling bactericidal activity of macrophages and CD8+ T cell differentiation
- (2019) Huynh Tan Hop et al. INFECTION AND IMMUNITY
- Combined blockade of IL-6 and PD-1/PD-L1 signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment
- (2018) Hirotake Tsukamoto et al. CANCER RESEARCH
- Immune checkpoint blockade combined with IL-6 and TGF-β inhibition improves the therapeutic outcome of mRNA-based immunotherapy
- (2018) Lukasz Bialkowski et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting Interleukin-6 (IL-6) Sensitizes Anti-PD-L1 Treatment in a Colorectal Cancer Preclinical Model
- (2018) Jibin Li et al. MEDICAL SCIENCE MONITOR
- Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
- (2016) Rashmi Bharti et al. CANCER LETTERS
- IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
- (2016) Thomas A Mace et al. GUT
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
- (2016) Sylvia Heink et al. NATURE IMMUNOLOGY
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site
- (2015) Maxime Thoreau et al. Oncotarget
- Therapeutic Peptide Vaccine-Induced CD8 T Cells Strongly Modulate Intratumoral Macrophages Required for Tumor Regression
- (2015) T. C. van der Sluis et al. Cancer Immunology Research
- Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation
- (2014) Ceri A. Fielding et al. IMMUNITY
- Interleukin-6, but not the interleukin-6 receptor plays a role in recovery from dextran sodium sulfate-induced colitis
- (2014) JAN SOMMER et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- A critical role for suppressor of cytokine signalling 3 in promoting M1 macrophage activation and functionin vitroandin vivo
- (2013) Christina E. Arnold et al. IMMUNOLOGY
- Cytokine patterns in patients with cancer: a systematic review
- (2013) Bodo E Lippitz LANCET ONCOLOGY
- Critical and Independent Role for SOCS3 in Either Myeloid or T Cells in Resistance to Mycobacterium tuberculosis
- (2013) Berit Carow et al. PLoS Pathogens
- Vaccine-Induced Effector-Memory CD8+ T Cell Responses Predict Therapeutic Efficacy against Tumors
- (2012) S. van Duikeren et al. JOURNAL OF IMMUNOLOGY
- Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2
- (2012) Sharon Cohen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- A Critical Role for SOCS3 in Innate Resistance to Toxoplasma gondii
- (2011) Ryan J. Whitmarsh et al. Cell Host & Microbe
- Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
- (2011) Jermaine Coward et al. CLINICAL CANCER RESEARCH
- Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2010) Yue Wang et al. CANCER LETTERS
- Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo
- (2009) Roland Axmann et al. ARTHRITIS AND RHEUMATISM
- The immunologic constant of rejection
- (2008) Ena Wang et al. TRENDS IN IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More